Biktarvy, formally known as bictegravir, represents a potent single-tablet regimen for treating HIV infection. This drug unites three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the HIV's ability to replicate within the body, considerably decreasing the viral load. For many individuals